event-trade登录编辑
PR Newswire All News ReleasesCodex · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 14:54:00·⟳ 抓取 14:54:22 +22s·⚡ 决策 08-31 14:55:52 +1m30s·57.2 天前

Insulet证券集体诉讼原告截止日提醒,无新增经营或诉讼事实

本次PR Newswire稿件与此前SBS多次投资者提醒实质相同,核心经营风险和医疗器械纠正信息已在3月、5月公开,诉讼提醒本身不改变Insulet基本面或短线预期差。

📄 原文PR Newswire All News Releases↗ 原文
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit LOS…
不做 Insulet Corporation(PODD.US)
不做:本条只是证券诉讼截止日重复提醒,底层产品纠正和同一诉讼招募已提前公开,缺少新增强空催化或可量化交易边际。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

事件来源可归属,但内容是证券诉讼律师广告式截止日提醒;同一诉讼招募信息此前已有多次公开传播,底层Omnipod医疗器械纠正也已由Insulet和FDA在数月前披露。本条没有新增处罚、召回扩大、赔偿金额、法院进展或公司确认的新负面事实,因此不具备可交易增量,回避PODD.US。

🔎 新鲜度:最早出现 2026-08-07 · 扩散 medium · price-in 风险 high ↗ ↗ ↗

消息传播链

  1. 2026-03-12官方确认/否认Insulet IR原文 ↗
    Insulet首次披露美国特定批次Omnipod 5 Pods自愿医疗器械纠正,这是诉讼叙事中的底层旧事实之一。
  2. 2026-05-26官方确认/否认Insulet IR/FDA原文 ↗
    Insulet和FDA披露另一项涉及美国及国际市场特定Omnipod批次的医疗器械纠正,底层产品问题已公开。
  3. 2026-08-07 09:45 ET财经媒体扩散GlobeNewswire/SBS非一手原文 ↗
    SBS已发布同一证券欺诈诉讼首席原告截止日提醒,说明8月31日稿不是首次出现。
  4. 2026-08-31 06:54 UTC财经媒体扩散PR Newswire/SBS非一手原文 ↗
    本次信号为截止日当天重复提醒,未增加诉讼认证、判决、和解金额或产品纠正范围扩大等事实。

主要风险

  • Insulet仍有Omnipod纠正和证券诉讼存量风险,但本条没有新增事实或量化损害,不能据此新开方向性交易。

反向证据

  • 做空前查反向 · 来源 web · 日期 2026-08-24 · 影响 weakens
    检索到8月24日PR Newswire/Morningstar同题提醒,未见新增判决、和解、监管处罚或召回范围扩大。
    检索:Insulet securities fraud lawsuit August 31 2026 lead plaintiff deadline new development 原文 ↗

先例如何影响了这次决策

对本次决策的影响:先例不足没有改变结论;决定性因素是本条已由更早同类提醒和底层公司/FDA披露覆盖。

方向:无需用外部先例校准方向;本条被判为无新增事实的律师事务所提醒,不是新的经营、监管或诉讼结果事件。

涨幅量级:没有新增可量化损害或交易价格锚点,先例涨跌幅不适合作为下单依据。

形态:律师事务所重复招募稿通常传播噪音大、基本面增量弱;本轮没有进入可交易先例测算。

工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
  1. web_search 成功 ? · 0 ms

原文全文

展开原文 · 3,093 字
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ: PODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
If you purchased Insulet Corporation securities you may be entitled to compensation without payment of any out-of-pocket fees or costs. Shareholders who purchased shares of PODD during the class period listed are encouraged to contact SBS to find out if they are eligible to recover their losses or lead this lawsuit. Appointment as lead plaintiff is not required to partake in any recovery. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
CLASS PERIOD: February 21, 2025 to May 26, 2026
DEADLINE: August 31, 2026
If you are a shareholder who suffered a loss, click here to participate.
Details of the Case: According to the Complaint, the Company made false and misleading statements to the market. Insulet suffered from defective controls over its manufacturing processes. The Company faced increased risks of safety violations due to these deficiencies. The Company's manufacturing problem necessitating its March 2026 Medical Device Cirrection impacted a greater number of its Pod Products than it claimed. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Insulet, investors suffered damages.
We encourage investors to contact Brian Schall and David Schwartz of Schall Brown & Schwartz, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
Join the case to recover your losses
Why SBS: Schall Brown & Schwartz represents investors around the world, specializing in securities class action lawsuits and shareholder rights litigation. SBS brings together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz. SBS attorneys and their co-counsel are responsible for recovering over a billion dollars for violations of securities laws and corporate misfeasance.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
Schall Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]
SOURCE Schall, Brown & Schwartz LLP

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。